|
AFF4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.169700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.852600E-01 |
| Normal-vs-Stage2 |
8.140000E-01 |
| Normal-vs-Stage3 |
5.876600E-03 |
| Normal-vs-Stage4 |
2.284400E-03 |
| Stage1-vs-Stage2 |
6.498600E-01 |
| Stage1-vs-Stage3 |
9.615100E-03 |
| Stage1-vs-Stage4 |
4.939000E-03 |
| Stage2-vs-Stage3 |
7.036200E-02 |
| Stage2-vs-Stage4 |
3.739900E-02 |
| Stage3-vs-Stage4 |
5.916600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.544810E-01 |
| Normal-vs-AfricanAmerican |
9.170400E-04 |
| Normal-vs-Asian |
6.608600E-01 |
| Caucasian-vs-AfricanAmerican |
9.780300E-03 |
| Caucasian-vs-Asian |
5.128400E-01 |
| AfricanAmerican-vs-Asian |
6.229700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.972000E-02 |
| Normal-vs-Female |
2.528400E-01 |
| Male-vs-Female |
6.011000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.785640E-02 |
| Normal-vs-Age(41-60Yrs) |
6.816800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.903890E-02 |
| Normal-vs-Age(81-100Yrs) |
5.295200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.160840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.910800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.826400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.254000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.530000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.951000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.659000E-01 |
| Normal-vs-Grade 2 |
8.578400E-01 |
| Normal-vs-Grade 3 |
7.592200E-02 |
| Normal-vs-Grade 4 |
2.34359999999878E-05 |
| Grade 1-vs-Grade 2 |
6.485400E-01 |
| Grade 1-vs-Grade 3 |
2.504800E-01 |
| Grade 1-vs-Grade 4 |
8.001200E-03 |
| Grade 2-vs-Grade 3 |
9.732200E-02 |
| Grade 2-vs-Grade 4 |
2.27449999999907E-05 |
| Grade 3-vs-Grade 4 |
5.177200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.510000E-01 |
| Normal-vs-ccB subtype |
6.417800E-02 |
| ccA subtype-vs-ccB subtype |
4.858200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.592600E-01 |
| Normal-vs-N1 |
1.439410E-01 |
| N0-vs-N1 |
2.751800E-01 |
|
|
